miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1(S) expression.
Sessa R, Trombetti S, Bianco AL, Amendola G, Catapano R, Cesaro E, Petruzziello F, D'Armiento M, Maruotti GM, Menna G, et al. Open Biol. 2024 Feb; 14(2):230319. Epub 2024 Feb 14.